Westlake Chemical Corporation published its Q1 2026 earnings call transcript, serving as an administrative record of the event. The document details company participants involved in the financial disc
Westlake Corporation raised its quarterly dividend to 53.3 cents and returned to profitability driven by improved pricing power and cost reductions, with analysts setting bullish targets near $90.
Walleye Capital LLC acquired a new position in Westlake Chemical Corporation, purchasing 82,847 shares worth approximately $6.05 million in Q2. This follows the company's better-than-expected quarterl
Assenagon Asset Management acquired a new 55,289-share stake in Westlake Chemical Corporation valued at $4.036 million during Q2. Other institutions adjusted holdings while brokerages maintain an aver
Westlake Chemical Corporation director Kimberly S. Lubel converted 2,168 restricted stock units into common stock on August 8, 2026. Her direct holdings increased to 13,821 shares following the one-fo
Westlake Chemical Corporation is scheduled to report earnings next week, with Wall Street forecasting $1.93 EPS and $3.28 billion revenue despite a Strong Sell rating and weak historical beat rates.
Westlake Chemical Partners LP is highlighted as a deeply undervalued commodity chemicals company with strong cash generation. Valuation metrics suggest the stock trades significantly below its intrins
Westlake Chemical Corporation stock volatility is analyzed via AI-driven trading strategies. Findings suggest positive near-term sentiment despite weak mid-term bias.
Westlake Chemical Partners shares traded below their 50-day moving average after Q1 earnings and revenue missed analyst estimates. Despite an elevated payout ratio, the company maintains a high annual
Corient Private Wealth LLC increased its stake in Westlake Chemical Corporation by 53.6% in Q4 to $3.75 million. Institutional investors raised positions despite weaker-than-expected quarterly earning
Antipodes Global Fund divested its stake in Westlake Chemical Corporation citing weak product demand and restructuring risks. The move signals diminished investor confidence in the chemical giant's ne
Citigroup maintains a Neutral rating on Westlake Chemical while lowering its price target to $85.00 amid cautious market outlooks. Significant insider sell-offs and mixed financial scores raise invest
Westlake Chemical Corp shares rose 17.7% year-to-date, prompting investor re-evaluation despite DCF analysis suggesting overvaluation. Analysts propose a fair value range between $70.00 and $114.29 ba
Westlake Chemical Corporation shares declined 13.5% following its latest earnings report, sparking investor debate on whether the stock will recover.
Citi downgraded Westlake Chemical to Neutral with a $95 price target due to weak PVC pricing and housing recovery, while JPMorgan also shifted to Neutral citing fair valuation despite polyethylene con
Diamond Hill Capital Management Inc. initiated a new position in Westlake Corporation, acquiring 190,180 shares worth approximately $14.1 million. This follows Westlake's weaker-than-expected quarterl
ChemBrief